ethinylestradiol - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NORIMIN 28 day tablet blister pack AUST R: 62133Active ingredients:
ethinylestradiol
norethisterone
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
18 Feb 2025
to
30 Apr 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling supply and working to expedite the next shipment.
|
NORIMIN-1 28 day tablet blister pack AUST R: 62136Active ingredients:
ethinylestradiol
norethisterone
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
26 Apr 2024
to
30 Apr 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
|
BROOKE drospirenone/ethinyloestradiol 3 mg/20 microgram tablet blister composite pack AUST R: 219081Active ingredients:
drospirenone
ethinylestradiol
Dosage form:
Tablet
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
19 Mar 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
BROOKLYNN drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack AUST R: 219080Active ingredients:
drospirenone
ethinylestradiol
Dosage form:
Tablet
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
Deletion from market:
19 Mar 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
PETIBELLE ethinylestradiol 30 microgram/ drospirenone 3 mg film coated tablet blister pack AUST R: 226240Active ingredients:
drospirenone
ethinylestradiol
Dosage form:
Tablet, film coated
Sponsor:
Bayer Australia Ltd
Phone:
1800008757
|
Deletion from market:
31 Jul 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|